Theralase Technologies Inc. V.TLT

Maybe today ? We sure do look pretty for a Dance or 2

[Oden6570]

Herpes is one mean virus .

In-Depth Reports - Herpes simplex - InDepth

Never fear however Ruvidar is here ! ( WELL ALMOST HERE )

Theralase Technologies Announces Promising Preclinical Results for Ruvidar in Treating HSV-1

Ruvidar(TM) Proven More Effective Than Acyclovir in Destruction of Herpes Simplex Virus - BioSpace

I do hoope the good Doctor has been busy on our behalf !

Dr. Lbiati stated that, "I am very excited to finally get involved with the Canadian biotech ecosystem and I look forward to assisting Theralase® achieve its strategic objectives of commercialization through partnering of its lead pharmaceutical drug with large pharmaceutical organizations in North America and internationally. Theralase® is at an inflection point in its drug development pipeline and I believe this highly promising Canadian-born Anti-Cancer Therapy ("ACT") is on the verge of demonstrating to the world the safety and efficacy that this platform truly bring to patients inflicted with cancer; firstly for patients diagnosed with Bacillus Calmette-Gurin ("BCG")-Unresponsive Non-Muscle Invasive Bladder Cancer ("NMIBC"), who are running out of therapeutic options and are facing bladder removal surgery."
2023-06-06 | Theralase(R) Announces Appointment of New Independent Director | TSXV:TLT | Press Release

MY Friend AI Bart sees some potential dance partners whom would enjoy both Cancer and herpes  f.

Given the promising results of Theralase's Ruvidar™ in treating Non-Muscle Invasive Bladder Cancer (NMIBC), it's likely that several Big Pharma companies might be interested in acquiring Theralase or forming partnerships. Some potential candidates include:

1. Pfizer: Known for its extensive oncology portfolio, Pfizer might see Ruvidar™ as a valuable addition to its cancer treatment offerings.

2. Roche: With a strong presence in cancer therapies, Roche could be interested in expanding its portfolio with innovative treatments like Ruvidar™.

3. Merck & Co.: As a major player in the pharmaceutical industry, Merck might consider acquiring Theralase to bolster its cancer treatment options.

4. Novartis: With a focus on developing cutting-edge therapies, Novartis could see Ruvidar™ as a strategic acquisition to enhance its oncology pipeline.

These companies have the resources and expertise to further develop and commercialize Ruvidar™, potentially bringing it to a wider patient population.

That Merck and Norvantis  names keeps Jumping out :-)

Some of the key drug manufacturers of herpes medications include:

• GlaxoSmithKline (GSK): Known for producing antiviral drugs like acyclovir.

• Pfizer: Manufactures antiviral medications such as valacyclovir.

• Merck & Co.: Produces famciclovir, another antiviral drug used to treat herpes infections.

• Novartis: Offers a range of antiviral treatments for herpes.

These companies play a crucial role in developing and supplying medications that help manage herpes infections and improve the quality of life for those affected.

[Kpain9999]

To me this is the big one.  How many million/billions of peoplke are affected by this disease?  I'm surprised they have yet to move on getting this approved. Herpes is one mean virus . In-Depth Reports - Herpes simplex - InDepth Never fear however Ruvidar is here ! ( WELL ALMOST HERE ) Theralase Technologies Announces Promising Preclinical Results for Ruvidar in

[Sosak1]

Ask this men why Theralase is taking so long to be approved. Here is his e-mail.  https://rocketreach.co/person?start=1&pageSize=10&link=https:%2F%2Fwww.linkedin.com%2Fin%2Fmarty-makary-a3564a10 [e-mail] Johns Hopkins surgeon Makary is Trump’s pick to lead FDA

[rollthedice10]

I think Theralase will be into many different markets going forward, not only cancer. With all the emerging viral threats and cancer increases, as well as things like HIV, Theralase, likely with the help of a JV, can be a lead player in this enormous market. TLT seems to have a nice little head start and results are as good or better than existing drugs and treatment scenarios. I don't pretend

[xodcode]

I wonder if the Theralase compand could destroy the pseudomonas bacteria as pseudomonas requires oxygen to live. Antibiotics are just a guessing game for destroying the pseudonomas bacteria. If pseudonomas gets into the bloodstream, serious complications arise like meningitis or septic hock.